Torrent Pharma to Launch ₹14,000 Crore Bond Issue After Regulatory Approval

is moving ahead with its proposed ₹14,000 crore bond issue after receiving approval from market regulator SEBI, according to banking sources familiar with the matter. The pharmaceutical major plans to raise funds in multiple tranches, leveraging the bond issue to strengthen its balance sheet and support ongoing business expansion. This marks one of the company’s largest debt-raising initiatives to date, aligning with its strategy to secure long-term funding at competitive rates. The proceeds are expected to be used for refinancing existing loans, meeting working capital requirements, and possibly funding strategic acquisitions or capacity expansions. With the regulatory clearance in place, bankers expect the first tranche of the bond issue to be launched in the coming weeks. Market analysts note that Torrent Pharma’s strong credit profile and consistent operational performance are likely to attract institutional investors. The company’s focus on the branded generics market and its robust cash flows from both domestic and international operations further enhance its appeal as an issuer. The move also comes at a time when several large corporates are tapping the bond market to take advantage of steady interest rates and growing investor appetite for high-quality debt instruments. Torrent Pharma’s upcoming bond issue is anticipated to bolster its financial flexibility and support long-term strategic initiatives as the company continues to expand its presence in key therapeutic areas and global markets. Source: The Economic Times No Recommendations